Search results for "nitric Oxide"
showing 10 items of 1075 documents
Implication of eNOS Uncoupling in Cardiovascular Disease
2017
Under physiological conditions, nitric oxide (NO) is produced in the vasculature mainly by the endothelial nitric oxide synthase (eNOS). Endothelial NO relaxes blood vessels, inhibits platelet activity, and protects against atherosclerosis. Under pathological conditions such as hypertension, diabetes, and hypercholesterolemia, eNOS may become uncoupled. Uncoupled eNOS generates superoxide at the expense of NO and contributes substantially to oxidative stress and endothelial dysfunction. Major mechanisms of eNOS uncoupling include deficiency of the eNOS cofactor tetrahydrobiopterin, deficiency of the eNOS substrate L-arginine, and eNOS S-glutathionylation. Reversal of eNOS uncoupling may rep…
Expression of Nitric Oxide Synthase I Determines the Strength of Adrenergic Cyclic GMP Response in the Rat Pineal Gland
1997
In the rat pineal gland the adrenergic cGMP response is not static but changes during postnatal development and depends on environmental lighting conditions. Since the adrenergic cGMP transduction is mediated by stimulation of the enzyme nitric oxide synthase I (NOS I), we investigated whether changes in the strength of adrenergic cGMP response coincide with the expression of NOS I. Using immunoblot analysis, we found that the increase in adrenergic cGMP transduction in the second postnatal week coincides with enhanced NOS I expression. Similarly, we observed that changes in the intensity of adrenergic cGMP transduction under different environmental lighting conditions correspond to NOS I e…
Post-Translational Regulation of Fas/CD95 in Cell Death and Survival: Role of Nitric Oxide
2010
Decision letter: Nitric oxide acts as a cotransmitter in a subset of dopaminergic neurons to diversify memory dynamics
2019
2013
Nitric oxide, produced by the neuronal nitric oxide synthase (nNOS) from L-arginine is an important second messenger molecule in the central nervous system: It influences the synthesis and release of neurotransmitters and plays an important role in long-term potentiation, long-term depression and neuroendocrine secretion. However, under certain pathological conditions such as Alzheimer’s or Parkinson’s disease, stroke and multiple sclerosis, excessive NO production can lead to tissue damage. It is thus desirable to control NO production in these situations. So far, little is known about the substrate supply to human nNOS as a determinant of its activity. Measuring bioactive NO via cGMP form…
Non-Vertebrate Nitric Oxide Synthases
2007
NO is an important signalling molecule making essential contributions to innate immunity in mammals. Interestingly, also several non-vertebral NOS have been described. Aside from a role in the feeding of bloodsucking insects, NO has been shown, for example, to play an important role in Drosophila innate immunity …
Involvement of Peroxynitrite on the Early Loss of P450 in Short-Term Hepatocyte Cultures
2001
The biological chemistry of nitric oxide (NO) in the oxygenated cellular environment is extremely complex. It involves the direct interaction of NO with specific biomolecules and the so-called indirect effects, due to secondary more potent oxidant species derived from NO which are also able to react with DNA, lipids, thiols and transition metals (Wink et al. 1996; Nathan, 1992). In addition to its regulatory role as a signalling molecule (Nathan, 1992; Moncada and Palmer, 1991) it has become evident that NO (or NO-derived species) is a critical factor involved in various toxicological mechanisms (Wink et al. 1996; Wang et al. 1998; Estevez et al. 1999; Wink et al. 1999). Some controversy ex…
Immunohistochemical localization of nitric oxide synthases
1996
Role of Nitric Oxide for Modulation of Cancer Therapy Resistance
2010
Reactive nitrogen species (RNS) act as central second messengers in a balanced cellular network. While the complexity of nitric oxide (NO) signaling is far from being understood, and many controversial data can be found in the literature, there is evidence for NO as a major player of modulation of resistance to anticancer drugs and radiotherapy. Hypoxia in cancer tissues causes therapy resistance, and the hypoxia-inducing factor-1 (HIF-1) plays a predominant role in hypoxia-induced resistance. NO and NO-donating compounds sensitize tumor cells by inhibiting HIF-1 mediated transcription in hypoxic cells. Among a plethora of other genes, HIF-1-induced the transcription of the multidrug resist…